Femasys vs Seastar Medical Holding
Femasys is the larger business, with $2.3m of revenue in fiscal 2025 against $1.2m for Seastar Medical Holding (1.9 times as much). Seastar Medical Holding grew faster (814.1% against 40.8%). Femasys kept more of each dollar of sales as profit: a net margin of -812.3% against -984.6%. Seastar Medical Holding carries less debt relative to equity (5.0% against 54.2%).
| Latest fiscal year | FemasysFEMY, 2025 | Seastar Medical HoldingICU, 2025 |
|---|---|---|
| Revenue | $2.3m | $1.2m |
| Revenue growth | 40.8% | 814.1% |
| Net income | −$18.6m | −$12.2m |
| Operating margin | -767.0% | -986.6% |
| Net margin | -812.3% | -984.6% |
| Return on equity | — | — |
| Free cash flow | −$19.2m | — |
| Cash | $9.3m | — |
| Total debt | $3.2m | $525,000 |
| Debt to equity | 54.2% | 5.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 51 | 17 |
| Market value | $4.1m | $8.3m |
| Price vs our value range | — | — |
| Moat score | 37 (Weak) | — |
| Insider trades, 12 months | 5 buys, 0 sales | 3 buys, 0 sales |